LDH News
-
-
Second Oversight Report: List of Conditions that Deem an Unborn Child Medically Futile
-
Second Oversight Report: LAC 51.II.107 Immunization Schedule
-
First Oversight Report: List of Conditions that Shall Deem an Unborn Child Medically FutileER
-
First Oversight Report: Regulation of Medical Marijuana ER
-
First Oversight Report: Registration of Food, Drugs, Cosmetics, and Prophylactic Devices
-
First Oversight Report: Immunization Schedule
-
Second Oversight Report: Molluscan Shellfish
-
Second Oversight Report: Consumable Hemp Potpourri
-
Second Oversight Report: Newborn Screening
Second Oversight Report for the proposed additions to the Newborn Screening Panel
-
Second Oversight Report: Consumable Hemp Products
Second oversight report for the proposed Consumable Hemp Products rule to be published in February 2022.
-
First Oversight Report: Newborn Screening
First oversight for proposed rule to include Spinal Muscular Atrophy (SMA), Mucopolysaccharidosis (MPS I), and Glycogen Storage Diseases Type II (Pompe Disease) to the Louisiana Newborn Screening Panel.